Features
ARVO 2023: Study Links Individual OSDI Responses to Clinical Measures, Spotlighting Possible Treatment
Tuesday, April 25 2023 | 12 h 50 min | NewsPress Release
CooperVision-Sponsored Research Among Multiple Scientific Works Presented with Clinical and University Partners
New SightGlass Vision Research Reinforces Myopia Control Efficacy and Safety of Diffusion Optics Technology™ Spectacle Lenses
Tuesday, April 25 2023 | 08 h 02 min | News, Press Release,
Studies Presented at ARVO 2023 Analyze and Evaluate Multiple Performance Characteristics, Including Positive 42-Month CYPRESS Axial Length and cSER Outcomes
New Specsavers Ad Brings Iconic Tag Line to Canada
Monday, April 24 2023 | 07 h 16 min | News, Press Release,
Specsavers consumer media campaign adopts iconic tag line used around the world.
EssilorLuxottica: Solid Start to the Year
Friday, April 21 2023 | 15 h 06 min | Financial News, Press Release,
EssilorLuxottica announced that consolidated revenue for the first quarter of 2023 reached Euro 6,151 million, representing a year-on-year increase of 8.6% at constant exchange rates compared to the first quarter of 2022.
CooperVision Seeks Proposals for 2023 Science and Technology Awards
Friday, April 21 2023 | 13 h 14 min | Awards, News, Press Release,
Global Program Enables Ophthalmic Researchers to Pursue New Concepts in Contact Lens Research and Development
ARVO 2023: Study Links Individual OSDI Responses to Clinical Measures, Spotlighting Possible Treatment
Tuesday, April 25 2023 | 12 h 50 min | NewsPress Release
CooperVision-Sponsored Research Among Multiple Scientific Works Presented with Clinical and University Partners
New SightGlass Vision Research Reinforces Myopia Control Efficacy and Safety of Diffusion Optics Technology™ Spectacle Lenses
Tuesday, April 25 2023 | 08 h 02 min | News, Press Release,
Studies Presented at ARVO 2023 Analyze and Evaluate Multiple Performance Characteristics, Including Positive 42-Month CYPRESS Axial Length and cSER Outcomes
New Specsavers Ad Brings Iconic Tag Line to Canada
Monday, April 24 2023 | 07 h 16 min | News, Press Release,
Specsavers consumer media campaign adopts iconic tag line used around the world.
EssilorLuxottica: Solid Start to the Year
Friday, April 21 2023 | 15 h 06 min | Financial News, Press Release,
EssilorLuxottica announced that consolidated revenue for the first quarter of 2023 reached Euro 6,151 million, representing a year-on-year increase of 8.6% at constant exchange rates compared to the first quarter of 2022.
CooperVision Seeks Proposals for 2023 Science and Technology Awards
Friday, April 21 2023 | 13 h 14 min | Awards, News, Press Release,
Global Program Enables Ophthalmic Researchers to Pursue New Concepts in Contact Lens Research and Development
ARVO 2023: Study Links Individual OSDI Responses to Clinical Measures, Spotlighting Possible Treatment
Tuesday, April 25 2023 | 12 h 50 min | NewsPress Release
CooperVision-Sponsored Research Among Multiple Scientific Works Presented with Clinical and University Partners
New SightGlass Vision Research Reinforces Myopia Control Efficacy and Safety of Diffusion Optics Technology™ Spectacle Lenses
Tuesday, April 25 2023 | 08 h 02 min | News, Press Release,
Studies Presented at ARVO 2023 Analyze and Evaluate Multiple Performance Characteristics, Including Positive 42-Month CYPRESS Axial Length and cSER Outcomes
New Specsavers Ad Brings Iconic Tag Line to Canada
Monday, April 24 2023 | 07 h 16 min | News, Press Release,
Specsavers consumer media campaign adopts iconic tag line used around the world.
EssilorLuxottica: Solid Start to the Year
Friday, April 21 2023 | 15 h 06 min | Financial News, Press Release,
EssilorLuxottica announced that consolidated revenue for the first quarter of 2023 reached Euro 6,151 million, representing a year-on-year increase of 8.6% at constant exchange rates compared to the first quarter of 2022.
CooperVision Seeks Proposals for 2023 Science and Technology Awards
Friday, April 21 2023 | 13 h 14 min | Awards, News, Press Release,
Global Program Enables Ophthalmic Researchers to Pursue New Concepts in Contact Lens Research and Development
ARVO 2023: Study Links Individual OSDI Responses to Clinical Measures, Spotlighting Possible Treatment
Tuesday, April 25 2023 | 12 h 50 min | NewsPress Release
CooperVision-Sponsored Research Among Multiple Scientific Works Presented with Clinical and University Partners
New SightGlass Vision Research Reinforces Myopia Control Efficacy and Safety of Diffusion Optics Technology™ Spectacle Lenses
Tuesday, April 25 2023 | 08 h 02 min | News, Press Release,
Studies Presented at ARVO 2023 Analyze and Evaluate Multiple Performance Characteristics, Including Positive 42-Month CYPRESS Axial Length and cSER Outcomes
New Specsavers Ad Brings Iconic Tag Line to Canada
Monday, April 24 2023 | 07 h 16 min | News, Press Release,
Specsavers consumer media campaign adopts iconic tag line used around the world.
EssilorLuxottica: Solid Start to the Year
Friday, April 21 2023 | 15 h 06 min | Financial News, Press Release,
EssilorLuxottica announced that consolidated revenue for the first quarter of 2023 reached Euro 6,151 million, representing a year-on-year increase of 8.6% at constant exchange rates compared to the first quarter of 2022.
CooperVision Seeks Proposals for 2023 Science and Technology Awards
Friday, April 21 2023 | 13 h 14 min | Awards, News, Press Release,
Global Program Enables Ophthalmic Researchers to Pursue New Concepts in Contact Lens Research and Development
